Respiratory syncytial virus hospitalisation burden in children below 18 years in six European countries (2016-2023) pre-and post-COVID-19 pandemic

Objectives: Respiratory syncytial virus (RSV) is a substantial cause of hospital admission in young children and leads to seasonal pressure on pediatric emergency units in most countries. This study aims to assemble national or large-scale data on RSV hospitalisations from six European countries wit...

Descripción completa

Detalles Bibliográficos
Autores: Jollivet, O, Urchueguia-Fornes, A, Chung-Delgado, K, Johannesen, CK, Lehtonen, T, Gideonse, D, Cohen, RA, Kramer, R, Orrico-Sánchez, A, Fischer, TK, Heikkinen, T, Van Boven, M, Nair, H, Campbell, H, Osei-Yeboah, R
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2025
País:España
Institución:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Repositorio:r-FISABIO. Repositorio Institucional de Producción Científica
OAI Identifier:oai:fisabio.fundanetsuite.com:p18950
Acceso en línea:https://fisabio.portalinvestigacion.com/publicaciones/18950
Access Level:acceso abierto
Palabra clave:Respiratory syncytial virus
Hospital burden
Children
Surveillance
COVID-19
Multi-country perspective
id ES_ef99f18ec78e40586d4d0db9f2a4bcad
oai_identifier_str oai:fisabio.fundanetsuite.com:p18950
network_acronym_str ES
network_name_str España
repository_id_str
spelling Respiratory syncytial virus hospitalisation burden in children below 18 years in six European countries (2016-2023) pre-and post-COVID-19 pandemicJollivet, OUrchueguia-Fornes, AChung-Delgado, KJohannesen, CKLehtonen, TGideonse, DCohen, RAKramer, ROrrico-Sánchez, AFischer, TKHeikkinen, TVan Boven, MNair, HCampbell, HOsei-Yeboah, RRespiratory syncytial virusHospital burdenChildrenSurveillanceCOVID-19Multi-country perspectiveObjectives: Respiratory syncytial virus (RSV) is a substantial cause of hospital admission in young children and leads to seasonal pressure on pediatric emergency units in most countries. This study aims to assemble national or large-scale data on RSV hospitalisations from six European countries with a standardised approach to provide recent burden data for all children and assess changes since SARS-CoV-2's emergence. Methods: We analysed 2016-2023 hospital records from national registries in Denmark, England, Finland, The Netherlands, and Scotland, and from a hospital surveillance network in Spain-Valencia for children below 18 years. We considered separately RSV-coded and RSV laboratory-confirmed cases, comparing them to respiratory tract infections. We studied the temporal evolution of incidence rates and case reporting practices, comparing pre-and post-COVID-19 periods. Results: Post-COVID-19 observed RSV hospital burden was similar to the pre-COVID-19 one for younger children but higher for the 1-2 years, 3-4 years, and 5-17 years age groups. No change in terms of coding-neither diagnosis nor RSV-coding when RSV was laboratory-confirmed-was detected. Conclusions: Hospital RSV burden in children is significant but currently not fully monitorable. Further efforts to harmonise coding practices both within and across countries would improve the quality of future analyses. Additional data in future seasons should complement current outcomes to inform decisions regarding RSV prevention. (c) 2025 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)ELSEVIER SCI LTD2025info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://fisabio.portalinvestigacion.com/publicaciones/18950INTERNATIONAL JOURNAL OF INFECTIOUS DISEASESISSN: 12019712ISSNe: 18783511reponame:r-FISABIO. Repositorio Institucional de Producción Científicainstname:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)Inglésinfo:eu-repo/semantics/openAccessoai:fisabio.fundanetsuite.com:p189502026-06-11T12:45:17Z
dc.title.none.fl_str_mv Respiratory syncytial virus hospitalisation burden in children below 18 years in six European countries (2016-2023) pre-and post-COVID-19 pandemic
title Respiratory syncytial virus hospitalisation burden in children below 18 years in six European countries (2016-2023) pre-and post-COVID-19 pandemic
spellingShingle Respiratory syncytial virus hospitalisation burden in children below 18 years in six European countries (2016-2023) pre-and post-COVID-19 pandemic
Jollivet, O
Respiratory syncytial virus
Hospital burden
Children
Surveillance
COVID-19
Multi-country perspective
title_short Respiratory syncytial virus hospitalisation burden in children below 18 years in six European countries (2016-2023) pre-and post-COVID-19 pandemic
title_full Respiratory syncytial virus hospitalisation burden in children below 18 years in six European countries (2016-2023) pre-and post-COVID-19 pandemic
title_fullStr Respiratory syncytial virus hospitalisation burden in children below 18 years in six European countries (2016-2023) pre-and post-COVID-19 pandemic
title_full_unstemmed Respiratory syncytial virus hospitalisation burden in children below 18 years in six European countries (2016-2023) pre-and post-COVID-19 pandemic
title_sort Respiratory syncytial virus hospitalisation burden in children below 18 years in six European countries (2016-2023) pre-and post-COVID-19 pandemic
dc.creator.none.fl_str_mv Jollivet, O
Urchueguia-Fornes, A
Chung-Delgado, K
Johannesen, CK
Lehtonen, T
Gideonse, D
Cohen, RA
Kramer, R
Orrico-Sánchez, A
Fischer, TK
Heikkinen, T
Van Boven, M
Nair, H
Campbell, H
Osei-Yeboah, R
author Jollivet, O
author_facet Jollivet, O
Urchueguia-Fornes, A
Chung-Delgado, K
Johannesen, CK
Lehtonen, T
Gideonse, D
Cohen, RA
Kramer, R
Orrico-Sánchez, A
Fischer, TK
Heikkinen, T
Van Boven, M
Nair, H
Campbell, H
Osei-Yeboah, R
author_role author
author2 Urchueguia-Fornes, A
Chung-Delgado, K
Johannesen, CK
Lehtonen, T
Gideonse, D
Cohen, RA
Kramer, R
Orrico-Sánchez, A
Fischer, TK
Heikkinen, T
Van Boven, M
Nair, H
Campbell, H
Osei-Yeboah, R
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Respiratory syncytial virus
Hospital burden
Children
Surveillance
COVID-19
Multi-country perspective
topic Respiratory syncytial virus
Hospital burden
Children
Surveillance
COVID-19
Multi-country perspective
description Objectives: Respiratory syncytial virus (RSV) is a substantial cause of hospital admission in young children and leads to seasonal pressure on pediatric emergency units in most countries. This study aims to assemble national or large-scale data on RSV hospitalisations from six European countries with a standardised approach to provide recent burden data for all children and assess changes since SARS-CoV-2's emergence. Methods: We analysed 2016-2023 hospital records from national registries in Denmark, England, Finland, The Netherlands, and Scotland, and from a hospital surveillance network in Spain-Valencia for children below 18 years. We considered separately RSV-coded and RSV laboratory-confirmed cases, comparing them to respiratory tract infections. We studied the temporal evolution of incidence rates and case reporting practices, comparing pre-and post-COVID-19 periods. Results: Post-COVID-19 observed RSV hospital burden was similar to the pre-COVID-19 one for younger children but higher for the 1-2 years, 3-4 years, and 5-17 years age groups. No change in terms of coding-neither diagnosis nor RSV-coding when RSV was laboratory-confirmed-was detected. Conclusions: Hospital RSV burden in children is significant but currently not fully monitorable. Further efforts to harmonise coding practices both within and across countries would improve the quality of future analyses. Additional data in future seasons should complement current outcomes to inform decisions regarding RSV prevention. (c) 2025 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)
publishDate 2025
dc.date.none.fl_str_mv 2025
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://fisabio.portalinvestigacion.com/publicaciones/18950
url https://fisabio.portalinvestigacion.com/publicaciones/18950
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv ELSEVIER SCI LTD
publisher.none.fl_str_mv ELSEVIER SCI LTD
dc.source.none.fl_str_mv INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
ISSN: 12019712
ISSNe: 18783511
reponame:r-FISABIO. Repositorio Institucional de Producción Científica
instname:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
instname_str Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
reponame_str r-FISABIO. Repositorio Institucional de Producción Científica
collection r-FISABIO. Repositorio Institucional de Producción Científica
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869423878650986496
score 15,812429

Similares en LA Referencia